Page 5 - Bardy Diagnostics News Today

Share it While attention focused on iRhythm Technologies after Medicare rates for long-term cardiac monitoring were slashed in January, the fallout is now extending to other players and the future of the much-hyped market is being questioned. Novitas Solutions, which sets regional Medicare rates as a Medicare Administrative Contractor, is working with iRhythm and rivals about possibly changing the published rates. However, there is no timetable for when — or if — the rates will change, lea...

H|T: The Healthtech Times H|T: The Healthtech Times – Subscription prescription The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!

Hillrom axed plans to acquire cardiac monitoring company Bardy Diagnostics over reimbursement changes by a Medicare contractor. Bardy filed suit against Hillrom on Sunday.

Share A January acquisition deal between medical technology provider Hillrom and cardiac monitoring device maker Bardy Diagnostics has landed in rocky waters, with Hillrom looking to back out of the purchase and Bardy filing a legal complaint to keep things moving forward. According to press releases from Hillrom, the company was caught off guard on January 29 when Novitas Solutions, a Medicare Administrative Contractor (MAC), published reimbursement rates for relevant CPT codes that were ...

Share: CHICAGO, March 1, 2021 /PRNewswire/ -- Hillrom (NYSE:HRC) today provided an update on its planned acquisition of Bardy Diagnostics, Inc. (BardyDx), which it previously announced on January 19, 2021.  On January 29, 2021, a Medicare Administrative Contractor, Novitas Solutions, published new Category 1 reimbursement rates applicable to the Current Procedural Terminology (CPT) codes for the long-term cardiac monitoring category, including CPT codes 93241, 93243, 93245 and 93247. As a re...

Hill-Rom Accused of Wrongfully Pulling Plug on Bardy Deal Mar 01 2021, 9:28 PM March 01 2021, 9:02 PM March 01 2021, 9:28 PM (Bloomberg) -- Hospital-bed maker Hill-Rom Holdings Inc. is accused of wrongfully pulling the plug on a $375 million buyout of startup Bardy Diagnostics over changes to government reimbursement rates for its cardiac-monitoring system.Officials of Seattle-based Bardy asked a Delaware judge to force Batesville, Indiana-based Hill-Rom to complete the acquisition, saying the ...

/PRNewswire/ -- Hillrom (NYSE: HRC) previously announced its intention to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health and a...

MedCity News Hillrom to buy cardiac monitoring company Bardy Diagnostics for $375M Hillrom will buy Bardy Diagnostics, a startup that makes a wearable ECG patch, for $375 million in cash. Shares0 In another deal for cardiac monitoring, Hillrom (NYSE: HRC) will buy Seattle-based startup Bardy Diagnostics for $375 million. The company, which was founded in 2013 by electrophysiologist Dr. Gust Bardy, makes an electrocardiogram (ECG) patch that can be worn for up to two weeks to help physicians d...

Share Cardiac-monitoring device maker Bardy Diagnostics has agreed to an acquisition by Hillrom, a medical technology provider specializing in smart hospital beds and other connected monitoring tools. The $375 million deal is expected to close during fiscal Q2 2021. Bardys flagship product is the Carnation Ambulatory Monitor, often referred to as the CAM patch. Its a P-wave signal-capturing wearable that is placed along the sternum, where it can remotely monitor patients’ cardiac activity...